Skip to content

Where Australia stands

The legal status of each substance in Australia, from the Poisons Standard and the TGA, beside the latest Australian news.

Key figures

active Authorised Prescribers for MDMA
61
as at 18 August 2026
active Authorised Prescribers for psilocybine
61
as at 18 August 2026
MDMA and psilocybine moved to Schedule 8 for two conditions
1 July 2023
all other uses stay in Schedule 9

Source: TGA, FOI 27-3566, data current to 18 August 2026

Legal status by substance

Checked on 20 November 2026 against the Poisons Standard, October 2026.

SubstanceStatus in the Poisons StandardRegistration and funding
Psilocybin (psilocybine)Schedule 8 for treatment-resistant depression when prescribed by a psychiatrist authorised under the Authorised Prescriber scheme, or in an approved clinical trial. Schedule 9 for every other use.TGA: accessing MDMA and psilocybine as a psychiatristNot on the Australian Register of Therapeutic Goods: an unapproved medicine.
MDMASchedule 8 for post-traumatic stress disorder when prescribed by a psychiatrist authorised under the Authorised Prescriber scheme, or in an approved clinical trial. Schedule 9 for every other use.TGA: prescribe MDMA or psilocybine (psychiatrists)Not on the Australian Register of Therapeutic Goods: an unapproved medicine.
EsketamineSchedule 8.TGA decision summary: SpravatoPBS medicine status: esketamineSpravato was registered on 9 March 2021 for treatment-resistant depression and listed on the Pharmaceutical Benefits Scheme on 1 May 2025.
KetamineSchedule 8. In October 2023 the TGA decided not to add further controls for use alongside psychotherapy.TGA final decision, October 2023None recorded here
LSD (lysergide)Schedule 9: a prohibited substance, available only for approved medical or scientific research.None recorded here
DMT (N,N-dimethyltryptamine)Schedule 9. Harmala alkaloids, the other component of ayahuasca, are also in Schedule 9 with narrow exceptions.None recorded here
MescalineSchedule 9.None recorded here
Psilocin (psilocine)Schedule 9.None recorded here
Ibogaine and noribogaineSchedule 4: prescription-only medicines.None recorded here

Limits of this page

  • States and territories add their own rules (for example, Victoria requires notification before each patient is treated). They are not listed here.
  • Rows without their own link come from the index of the current Poisons Standard.
  • The table is checked by hand, so it can lag a new instrument. The date above says when it was last checked.

Please note

This page describes the law and public records. It is not medical or legal advice and not an invitation to seek treatment. No MDMA or psilocybin product is on the Australian Register of Therapeutic Goods; only TGA-authorised psychiatrists can prescribe them. Speak to your GP.

Latest from Australia

4 NovWed
8 JunMon
  1. TGA: interim scheduling decisions (Australia)62

    TGA publishes interim scheduling decisions on Poisons Standard amendments from ACMS #47 and Joint ACMS-ACCS #40

    The TGA has published its interim decisions on proposed amendments to the Poisons Standard considered at ACMS #47 and Joint ACMS-ACCS #40, and invites comment. The closing date for submissions is 10 July 2026. The notice is a summary only and does not list the substances or amendments covered.

    Why it matters: The notice marks the interim stage of scheduling, so anyone with an interest in the proposed Poisons Standard amendments has until 10 July 2026 to comment before a final decision.

28 MayThu
24 MaySun
  1. TGA: final scheduling decisions (Australia)62

    TGA publishes final Poisons Standard decisions from ACCS #40 and Joint ACMS-ACCS #39

    The TGA has published its notice of final decisions on whether to amend the Poisons Standard, following the Advisory Committee on Chemicals Scheduling (ACCS) #40 and the Joint Advisory Committee on Medicines Scheduling and Advisory Committee on Chemicals Scheduling (Joint ACMS-ACCS) #39. The publication is issued under regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990. The feed supplied only a summary, so the specific substances and outcomes are not stated here.

    Why it matters: The notice is the formal record of which scheduling proposals were accepted or rejected, so companies and prescribers can check whether a compound's legal status changed.

20 MayWed
18 MayMon
17 Dec 2025Wed
  1. TGA: interim scheduling decisions (Australia)58

    TGA publishes interim decisions on proposed Poisons Standard amendments from ACCS #40 and Joint ACMS-ACCS #39

    The TGA has published interim decisions on proposed amendments to the Poisons Standard arising from the Advisory Committee on Chemicals Scheduling (ACCS) #40 and the Joint Advisory Committee on Medicines Scheduling and Advisory Committee on Chemicals Scheduling (Joint ACMS-ACCS) #39. The notice invites comment, with a closing date of 23 January 2026. The feed gave no further detail on which substances or schedules the interim decisions cover.